XML 16 R5.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common stock
Additional paid in capital
Accumulated deficit
Accumulated other comprehensive income
Beginning balance (in shares) at Dec. 31, 2022   141,590      
Beginning balance at Dec. 31, 2022 $ 227,335 $ 0 $ 226,327 $ (38,443) $ 39,451
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense 50,970   50,970    
Stock issued under stock incentive plans, net (in shares)   158      
Stock issued under stock incentive plans, net (150)   (150)    
Repurchase of common stock under share repurchase program (in shares)   (45)      
Repurchase of common stock under share repurchase program (699)   (699)    
Dividends declared (262,213)     (262,213)  
Proceeds from initial public offering, net of underwriting fees and offering costs (in shares)   18,750      
Proceeds from initial public offering, net of underwriting fees and offering costs of $42,473 295,027   295,027    
Comprehensive income (loss) 2,872     9,243 (6,371)
Ending balance (in shares) at Sep. 30, 2023   160,453      
Ending balance at Sep. 30, 2023 313,142 $ 0 571,475 (291,413) 33,080
Beginning balance (in shares) at Jul. 01, 2023   141,703      
Beginning balance at Jul. 01, 2023 (12,571) $ 0 227,335 (275,801) 35,895
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense 49,113   49,113    
Proceeds from initial public offering, net of underwriting fees and offering costs (in shares)   18,750      
Proceeds from initial public offering, net of underwriting fees and offering costs of $42,473 295,027   295,027    
Comprehensive income (loss) (18,427)     (15,612) (2,815)
Ending balance (in shares) at Sep. 30, 2023   160,453      
Ending balance at Sep. 30, 2023 $ 313,142 $ 0 571,475 (291,413) 33,080
Beginning balance (in shares) at Dec. 30, 2023 160,453 160,453      
Beginning balance at Dec. 30, 2023 $ 376,055 $ 0 593,109 (247,541) 30,487
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense 51,107   51,107    
Stock issued under stock incentive plans, net (in shares)   1,724      
Stock issued under stock incentive plans, net 2,890   2,890    
Repurchase of common stock under share repurchase program (in shares)   (2,071)      
Repurchase of common stock under share repurchase program (20,934)     (20,934)  
Comprehensive income (loss) $ 23,765     30,926 (7,161)
Ending balance (in shares) at Sep. 28, 2024 160,106 160,106      
Ending balance at Sep. 28, 2024 $ 432,883 $ 0 647,106 (237,549) 23,326
Beginning balance (in shares) at Jun. 29, 2024   161,702      
Beginning balance at Jun. 29, 2024 419,455 $ 0 636,494 (241,612) 24,573
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense 10,328   10,328    
Stock issued under stock incentive plans, net (in shares)   187      
Stock issued under stock incentive plans, net 284   284    
Repurchase of common stock under share repurchase program (in shares)   (1,783)      
Repurchase of common stock under share repurchase program (17,618)     (17,618)  
Comprehensive income (loss) $ 20,434     21,681 (1,247)
Ending balance (in shares) at Sep. 28, 2024 160,106 160,106      
Ending balance at Sep. 28, 2024 $ 432,883 $ 0 $ 647,106 $ (237,549) $ 23,326